Medicare Enrolled

Dr. Margaret Wong Gribble, MD

Ophthalmology · Atlanta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3225 CUMBERLAND BLVD SE STE 800, Atlanta, GA 30339
4043512220
In practice since 2008 (18 years)
NPI: 1477723187 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wong Gribble from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wong Gribble? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wong Gribble

Dr. Margaret Wong Gribble is an ophthalmology specialist in Atlanta, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wong Gribble performed 30,041 Medicare services across 2,576 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wong Gribble received a total of $320,412 from 33 pharmaceutical and/or device companies across 625 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wong Gribble is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 3% volume in GA $320,412 industry payments

Medicare Practice Summary

Medicare Utilization ↗
30,041
Medicare services
Top 3% in GA for ophthalmology
2,576
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,669 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
22,320 $29 $94
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,290 $90 $321
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,258 $30 $102
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,233 $94 $910
Injection, ranibizumab, 0.1 mg 1,104 $182 $430
Aflibercept eye injection (Eylea) 1,096 $692 $2,400
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
1,037 $27 $154
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
276 $54 $391
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
198 $109 $345
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
55 $115 $418
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
38 $83 $317
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
38 $66 $227
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
29 $18 $62
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
21 $272 $2,038
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
18 $377 $2,336
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
18 $36 $271
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
12 $46 $157
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$320,412
Total received (2018-2024)
Avg $45,773/year across 7 years
Top 1% in GA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
625
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$304,188 (94.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,697 (2.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,527 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$93,806
2023
$88,191
2022
$33,732
2021
$20,564
2020
$23,771
2019
$35,642
2018
$24,707

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$84,577
Astellas Pharma US Inc
$5,600
Oyster Point Pharma, Inc.
$1,800
ABBVIE INC.
$423
Regeneron Healthcare Solutions, Inc.
$398
Genentech USA, Inc.
$291
Alimera Sciences, Inc.
$202
Glaukos Corporation
$192
Bausch & Lomb Americas Inc.
$102
Apellis Pharmaceuticals, Inc.
$91
Biogen, Inc.
$58
Alcon Vision LLC
$29
ANI Pharmaceuticals, Inc.
$23
Coherus Biosciences Inc.
$20
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$235,299
AbbVie, Inc.
$34,229
Mallinckrodt Enterprises LLC
$18,494
EyePoint Pharmaceuticals US, Inc.
$6,910
Allergan Inc.
$5,762
Astellas Pharma US Inc
$5,631
AbbVie Inc.
$4,000
Oyster Point Pharma, Inc.
$1,800
Regeneron Healthcare Solutions, Inc.
$1,572
Genentech USA, Inc.
$1,307
Alimera Sciences, Inc.
$661
Novartis Pharmaceuticals Corporation
$640
Kala Pharmaceuticals, Inc.
$615
ABBVIE INC.
$580
Biogen, Inc.
$430
Mallinckrodt LLC
$349
Glaukos Corporation
$338
Bausch & Lomb Americas Inc.
$320
Horizon Therapeutics plc
$224
Bausch & Lomb, a division of Bausch Health US, LLC
$163
Apellis Pharmaceuticals, Inc.
$148
Shire North American Group Inc
$144
BIOTISSUE HOLDINGS, INC.
$144
Coherus Biosciences Inc.
$122
Sun Pharmaceutical Industries Inc.
$113
Spark Therapeutics, Inc.
$96
Allergan, Inc.
$67
ANI Pharmaceuticals, Inc.
$66
Johnson & Johnson Surgical Vision, Inc.
$57
Akorn, Inc.
$53
Alcon Vision LLC
$51
TISSUETECH, INC.
$15
OPTOS, INC.
$14
Top 3 companies account for 89.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROLUCIZUMAB · BYOOVIZ · COMBIGAN · Catalys System · Cequa · Cimerli · DUREZOL · DURYSTA · EYLEA · EYLEA HD · EYSUVIS · HUMIRA · Humira · ILUVIEN · INVELTYS · Iluvien · Izervay · LOTEMAX SM · LUMIGAN · LUXTURNA · Lucentis · MIEBO · Monaco · OZURDEX · PROKERA · PROLENSA · PURIFIED CORTROPHIN GEL · RINVOQ · Rhopressa · Rocklatan · SUSVIMO · Syfovre · TEPEZZA · VABYSMO · Vabysmo · XIIDRA · XIPERE · YUTIQ · Zioptan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for ophthalmology in GA.

Looking for an ophthalmology specialist in Atlanta?
Compare ophthalmologists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
245
Per 100K population
31.9
County median income
$98,712
Nearest hospital
RIDGEVIEW INSTITUTE
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wong Gribble is a mixed practice specialist, with above-average Medicare volume (top 3% in GA), with speaking/promotional industry engagement in the top 1% of GA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wong Gribble experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Wong Gribble performed 22,320 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wong Gribble receive payments from pharmaceutical companies?
Yes. Dr. Wong Gribble received a total of $320,412 from 33 companies across 625 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wong Gribble's costs compare to other ophthalmologists in Atlanta?
Dr. Wong Gribble's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wong Gribble) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →